FedEx delivered its June 23 earnings print — and the Street's reaction tells the whole story: a wave of same-day target cuts from analysts who still won't sell the stock.
The analyst response is the defining event of this week. Multiple firms moved within hours of the release. UBS cut its target from $445 to $350 while holding Buy. Stifel dropped from $442 to $326 — a 26% reduction — also keeping Buy. B of A Securities, the outlier, actually nudged its target higher, from $376 to $378, and maintained Buy. Those three moves alone illustrate the tension: the bulls haven't turned, but their conviction is clearly cheaper than it was a month ago. UBS and Stifel's cuts are among the largest in recent memory for a firm that isn't downgrading. Wells Fargo and Barclays had already trimmed targets in the days before the print. Morgan Stanley remains the lone explicit bear, with an Underweight and a $160 target — a reading so far below the current $317.24 price that it reflects a fundamentally different thesis from the rest of the Street. With 16 buys against 7 holds, the consensus is still constructive, but the mean target has compressed toward $347.57, leaving implied upside of roughly 9% — thin by historical standards for a name with this many Buy ratings.
The stock absorbed the earnings reaction badly. FDX closed at $317.24, down 3.5% on the day and 5.5% on the week — extending the month's decline to nearly 20%. That's a sharper drawdown than close peers. gained 2.3% on the day and was roughly flat on the week. also bounced 2.2% on Tuesday. FedEx did not. The divergence is notable: sector pressure is real, but FedEx is absorbing a company-specific discount on top of it. The valuation compression is visible in the multiples — the P/E has contracted about 3.3 points over the past month to 15.7x, and price-to-book has fallen roughly 0.8 points to 2.2x. EV/EBITDA at 10.4x is rising modestly, partly because the stock is falling faster than earnings estimates are being revised down.
The lending market is entirely unconstrained — availability is effectively unlimited, with 190 million shares available to borrow against a short position of under 4 million. Short interest at 1.6% of the free float is negligible and fell sharply on Tuesday, dropping 21% in a single session after a modest build earlier in the week. Borrow costs have crept higher over the past month, up roughly 41%, but at 0.47% they remain trivially low. This is not a short-driven move. Options positioning has also eased from the pre-earnings defensiveness flagged in prior notes — the put/call ratio pulled back to 1.36, right at its 20-day average, with a z-score near zero. The hedging crowd that was loading up ahead of the binary event has largely stepped away. What remains is a fundamental repricing.
The insider picture adds one layer of context worth noting. The most recent insider data covers through early May, and the picture was uniformly negative — CEO Raj Subramaniam sold nearly $6.3 million of stock in late April, joined by the General Counsel, an EVP, and multiple directors selling in the $360-$390 range. Those sales were executed at prices 13-20% above where the stock trades today. Net insider activity over the 90-day window through May 5 totaled approximately $35.8 million in sales. None of these trades were made with current information, but the pattern suggests insiders were reducing exposure as the stock approached levels it has since fallen well below.
Factor scores reinforce the mixed picture. The analyst recommendation divergence score ranks in the 93rd percentile — an unusually wide spread of views for a large-cap name. Dividend score ranks at the 100th percentile, though the dividend data in the system is stale and may not reflect current policy. EPS momentum over 30 days ranks in just the 22nd percentile, confirming that forward estimate revisions have been running negative. The short score of 30.5 is benign and has been stable all week.
What to watch next is whether the post-earnings analyst community converges on a more consistent target range — right now the spread from $160 to $460 is unusually wide, and the next meaningful update will come with Q1 fiscal 2027 guidance commentary ahead of the October 28 earnings event.
See the live data behind this article on ORTEX.
Open FDX on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
